The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer

In this review article, we address the impact of SBRT in oligometastatic NSCLC, the most relevant prognostic factors, indications and a site specific review. This review will focus on SBRT for extracranial disease as the role for intracranial SBRT is established.